Why a Patient of Gasteric Cancer should take Eannatto Tocotrienol?
Gastric cancer is the fourth most commonly occurring in men and the seventh most commonly occurring cancer in women. According to stats given by wcrf.org, Gastric cancer has a very high mortality rate and around 1 million new cases were registered worldwide in 2018! Conventional treatments for cancer like surgery, radiation, and chemotherapy have failed to completely eliminate gastric cancer.Although, several studies have been conducted on Tocotrienol (Eannatto) and its effects on Gastric Cancer and one of them is ‘First Evidence That Gamma-Tocotrienol Inhibits the Growth of Human Gastric Cancer and Chemosensitizes it to Capecitabine in a Xenograft Mouse Model through the Modulation of NF-kB Pathway’ where it was observed that Tocotrienol could potentiate the effects of capecitabine through suppression of NF-kB-regulated markers of proliferation, invasion, angiogenesis, and metastasis.
Why Tocotrienol and Not Tocopherol?
Read Other Studies:
- Tocotrienols: The Promising Analogues of Vitamin Efor Cancer Therapeutics https://doi.org/10.1016/j.phrs.2018.02.017
- First Evidence That Gamma-Tocotrienol Inhibits the Growth of Human Gastric Cancer and Chemosensitizes it to Capecitabine in a Xenograft Mouse Model through the Modulation of NF-kB Pathway http://clincancerres.aacrjournals.org/content/clincanres/18/8/2220.full.pdf
- Stomach Cancer Statistics https://www.wcrf.org/dietandcancer/cancer-trends/stomach-cancer-statistics